IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP IV, LLC

Q2 2023 Holdings

Filed 2023-08-10 | 3 holdings | $110.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tango Therapeutics, Inc.(TNGX)COM87583X109$64.3M19,363,97558.1%
Pliant Therapeutics, Inc.(PLRX)COM729139105$38.6M2,132,86734.9%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$7.7M2,343,1547.0%